|1.||Malavasi, Fabio: 2 articles (09/2007 - 03/2004)|
|2.||Mehta, Kapil: 2 articles (04/2007 - 03/2004)|
|3.||Saxena, Renu: 1 article (06/2014)|
|4.||Dutta, Shyamali: 1 article (06/2014)|
|5.||Wood, Brent L: 1 article (02/2014)|
|6.||Hylarides, Mark D: 1 article (02/2014)|
|7.||Wilbur, D S: 1 article (02/2014)|
|8.||Kenoyer, Aimee L: 1 article (02/2014)|
|9.||Gopal, Ajay K: 1 article (02/2014)|
|10.||Jones, Jon C: 1 article (02/2014)|
|1.||HIV Infections (HIV Infection)
03/15/1996 - "Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up."
10/01/2004 - "Our findings support the importance of expression of CD38 antigen on CD8+ T-lymphocytes as a biological and clinical marker of HIV infection and indicate its usefulness for monitoring of the efficacy of HAART therapy."
04/01/1998 - "During acute EBV infection, CD8+ cells expressed elevated levels of the activation antigens CD38 and HLA-DR, similar to that during chronic HIV infection. "
11/01/1999 - "Clearance of vaginal deltaTK- -HSV-2 infection was compared between mice with normal gammadelta T cell populations (BALB/c) and transgenic mice in which all the gammadelta T cells express a receptor that is specific for the b allotype of MHC class Ib T10 antigen (G8/BALB/c). "
09/01/2005 - "Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection."
11/01/2011 - "The aim of our study was to evaluate the clinical value of CD38 antigen and ZAP-70 expression as predictors of the disease progression and to analyze the correlation of these markers with other B-CLL prognostic markers. "
10/01/1997 - "Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression."
03/01/2004 - "The purpose of this study was to determine whether the RA-induced CD38 antigen could be a target for an anti-CD38-based immunotoxin to induce selective killing of leukemia cells. "
03/01/2004 - "Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells."
04/01/2007 - "Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome."
|5.||Paraproteinemias (Monoclonal Gammopathy)
|1.||Biological Markers (Surrogate Marker)
|2.||DNA (Deoxyribonucleic Acid)
|4.||Tretinoin (Retinoic Acid)
|6.||HLA-DR Antigens (HLA-DR)
|7.||Interleukin-1beta (Interleukin 1 beta)
|10.||CD3 Antigens (CD3 Complex)
|1.||Highly Active Antiretroviral Therapy (HAART)